1. Home
  2. PACB

PACB

Pacific Biosciences of California Inc.

Logo Pacific Biosciences of California Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Founded: 2000 Country:
United States
United States
Employees: N/A City: MENLO PARK
Market Cap: 375.1M IPO Year: 2010
Target Price: $7.77 AVG Volume (30 days): 9.6M
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.21 EPS Growth: N/A
52 Week Low/High: $3.13 - $14.55 Next Earning Date: 05-09-2024
Revenue: $200,521,000 Revenue Growth: 56.29%
Revenue Growth (this year): 21.48% Revenue Growth (next year): 45.55%

Share on Social Networks:

Stock Insider Trading Activity of Pacific Biosciences of California Inc. (PACB)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Meline David W PACB Director Mar 6 '24 Buy $4.40 40,000 $176,160.00 40,000 SEC Form 4